Kestra Private Wealth Services, LLC Phathom Pharmaceuticals, Inc. Transaction History
Kestra Private Wealth Services, LLC
- $5.3 Billion
- Q3 2024
A detailed history of Kestra Private Wealth Services, LLC transactions in Phathom Pharmaceuticals, Inc. stock. As of the latest transaction made, Kestra Private Wealth Services, LLC holds 10,000 shares of PHAT stock, worth $80,000. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,000
Previous 10,000
-0.0%
Holding current value
$80,000
Previous $103,000
74.76%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding PHAT
# of Institutions
144Shares Held
73.6MCall Options Held
42.3KPut Options Held
45.7K-
Frazier Life Sciences Management, L.P. Menlo Park, CA10.1MShares$80.9 Million9.84% of portfolio
-
Medicxi Ventures Management (Jersey) LTD7.46MShares$59.7 Million28.04% of portfolio
-
Jennison Associates LLC5.87MShares$46.9 Million0.07% of portfolio
-
Invesco Ltd. Atlanta, GA4.1MShares$32.8 Million0.01% of portfolio
-
Carlyle Group Inc. Washington, DC3.5MShares$28 Million9.52% of portfolio
About Phathom Pharmaceuticals, Inc.
- Ticker PHAT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 39,175,200
- Market Cap $313M
- Description
- Phathom Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing treatments for gastrointestinal diseases. The company has the rights in the United States, Europe, and Canada to vonoprazan, a potassium-competitive acid blocker (P-CAB) that blocks acid secretion in the stomach. It is also develo...